Scientists test mRNA tech to fight tough blood cancers
NCT ID NCT07362732
Summary
This early study is testing a new mRNA-based injection called WGb-0302 for patients with blood cancers like multiple myeloma that have returned or stopped responding to standard treatments. The treatment uses technology similar to some COVID-19 vaccines to deliver instructions that target a specific protein on cancer cells. The main goals are to find a safe dose and see if the treatment can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.